Cargando…

Novel Strategies for Cancer Combat: Drug Combination Using Repurposed Drugs Induces Synergistic Growth Inhibition of MCF-7 Breast and HT-29 Colon Cancer Cells

Our group developed a new model of drug combination consisting of the use of antineoplastic drugs and different repurposed drugs, having demonstrated that antimalarial and central nervous system (CNS) drugs have a promising anticancer profile as standalone agents, as well as in combined regimens. He...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duarte, Diana, Guerreiro, Inês, Vale, Nuno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601176/ https://www.ncbi.nlm.nih.gov/pubmed/36286050 http://dx.doi.org/10.3390/cimb44100335

Ejemplares similares

Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs
por: Duarte, Diana, et al.
Publicado: (2021)

Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines
por: Duarte, Diana, et al.
Publicado: (2022)

Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action
por: Duarte, Diana, et al.
Publicado: (2022)

Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Drug Repurposing in Cancer Therapy: Influence of Patient’s Genetic Background in Breast Cancer Treatment
por: Rodrigues, Rafaela, et al.
Publicado: (2022)

Synergistic Interaction of CPP2 Coupled with Thiazole Derivates Combined with Clotrimazole and Antineoplastic Drugs in Prostate and Colon Cancer Cell Lines
por: Duarte, Diana, et al.
Publicado: (2021)

Repurposing of the Drug Tezosentan for Cancer Therapy
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

Improvement of the In Vitro Cytotoxic Effect on HT-29 Colon Cancer Cells by Combining 5-Fluorouacil and Fluphenazine with Green, Red or Brown Propolis
por: Falcão, Soraia I., et al.
Publicado: (2023)

Pharmacological Efficacy of Repurposing Drugs in the Treatment of Prostate Cancer
por: Lourenço, Tânia, et al.
Publicado: (2023)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Combination of CNTs with Classical Drugs for Treatment in Human Colorectal Adenocarcinoma (HT-29) Cell Line
por: Abreu, Sara, et al.
Publicado: (2023)

Drug combination and repurposing for cancer therapy: the example of breast cancer
por: Correia, Ana Salomé, et al.
Publicado: (2021)

Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
por: El Zarif, Talal, et al.
Publicado: (2022)

Combating devastating COVID-19 by drug repurposing
por: Pawar, Ashish Yashwantrao
Publicado: (2020)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

The Role of Dopamine in Repurposing Drugs for Oncology
por: Moura, Catarina, et al.
Publicado: (2023)

Repurposing Salicylanilide Anthelmintic Drugs to Combat Drug Resistant Staphylococcus aureus
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2015)

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)

Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018)

A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19
por: Costa, Bárbara, et al.
Publicado: (2021)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

In Vitro Drug Repurposing: Focus on Vasodilators
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

Antidepressant Drug Sertraline against Human Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Antipsychotic Drug Fluphenazine against Human Cancer Cells
por: Duarte, Diana, et al.
Publicado: (2022)

Repurposing and Revival of the Drugs: A New Approach to Combat the Drug Resistant Tuberculosis
por: Sharma, Divakar, et al.
Publicado: (2017)

Drug repurposing screens and synergistic drug‐combinations for infectious diseases
por: Zheng, Wei, et al.
Publicado: (2017)

Synergistic drug combinations and machine learning for drug repurposing in chordoma
por: Anderson, Edward, et al.
Publicado: (2020)

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens
por: Thangamani, Shankar, et al.
Publicado: (2015)

Combating COVID-19: The role of drug repurposing and medicinal plants
por: Khan, Shah A., et al.
Publicado: (2021)

Editorial: Repurposed Drugs as Immune-Modulators to Combat Infectious Diseases
por: Mishra, Bibhuti B., et al.
Publicado: (2022)

Rottlerin Inhibits ROS Formation and Prevents NFκB Activation in MCF-7 and HT-29 Cells
por: Maioli, Emanuela, et al.
Publicado: (2009)

Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations
por: Correia, Ana, et al.
Publicado: (2018)

Genistein Induces Apoptosis and Inhibits Proliferation of HT29 Colon Cancer Cells
por: Shafiee, Gholamreza, et al.
Publicado: (2016)

Radiotherapy Enhancement with Electroporation in Human Intestinal Colon Cancer HT-29 Cells
por: Yadollahpour, Ali, et al.
Publicado: (2018)

Effects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells
por: Mombeini, Maryam, et al.
Publicado: (2018)

Mechanism of Pterostilbene-Induced Cell Death in HT-29 Colon Cancer Cells
por: Wawszczyk, Joanna, et al.
Publicado: (2022)

HT-29 Colon Cancer Cell Electromanipulation and Assessment Based on Their Electrical Properties
por: Olariu, Marius Andrei, et al.
Publicado: (2022)

Clinical features and mechanistic insights into drug repurposing for combating COVID-19
por: Asrani, Purva, et al.
Publicado: (2022)

Inhibition of Human MCF-7 Breast Cancer Cells and HT-29 Colon Cancer Cells by Rice-Produced Recombinant Human Insulin-Like Growth Binding Protein-3 (rhIGFBP-3)
por: Cheung, Stanley C. K., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n2msv92928kuauee3g9mmft0bd